Speaker illustration

undefined undefined undefined

Rivaroxaban treatment prevents atrial myocyte hypertrophy in goats with persistent atrial fibrillation by inhibition of protease activated receptor 1

Event: EHRA 2025

Topic: Cellular Mechanisms of Arrhythmias

Session: Young Investigator Award Basic and Translational Science

Thumbnail

Atrial fibrillation and age synergistically increase clotting potential and promote atrial structural remodeling in goats

Event: EHRA 2022

Topic: Arrhythmias

Session: ePosters Day 2

Thumbnail

ESC 365 is supported by